Signaling Pathways - eIF4F - Purinergic (P2Y) Receptors - Insulin-like growth factors (IGFs) - Androgen Receptors
清除全部
- A8452 ODM-201中文名: 达洛鲁胺Target: Androgen ReceptorsSummary: 新一代雄激素受体抑制剂
- B4634 AZD1283Target: Purinergic (P2Y) ReceptorsSummary: P2Y12拮抗剂
- B3697 4E1RCatTarget: eIF4FSummary: eIF4E:eIF4G与eIF4E:4E-BP1相互作用的双重抑制剂
- B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂
- A8623 TOK-001中文名: 加来特龙,伽来特隆Target: Androgen Receptors|Cytochrome P450 (CYP450)Summary: CYP17抑制剂和雄激素受体(AR)拮抗剂
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂
- A2150 AndarineTarget: Androgen ReceptorsSummary: 雄激素受体拮抗剂
- A5065 Bicalutamide1 Citation中文名: 比卡鲁胺Target: Androgen ReceptorsSummary: 雄激素受体(Androgen receptor)拮抗剂
- A3003 MDV3100 (Enzalutamide)12 Citation中文名: 恩杂鲁胺Target: Androgen ReceptorsSummary: 雄激素受体拮抗剂。